Table of Contents
WOODCLIFF LAKE, N.J. — Thomas Haughey has been named president and Paul Campanelli has been appointed chief operating officer at Par Pharmaceutical Cos.
The company said Tuesday that the promotions are effective immediate and that Haughey and Campanelli will continue to report to Patrick LePore, who will remain chairman and chief executive officer.
Haughey has served as chief administrative officer since 2008, Executive Vice President since 2006, and general counsel and secretary since joining Par in 2003. The company noted that he brings over 25 years of accounting, legal and pharmaceutical experience to his new role as President.
In addition to his title as COO, Campanelli will retain the title of president of Par Pharmaceutical, the company’s generics division, plus assume responsibility for Strativa Pharmaceuticals, the branded division. He started his career at Par in 2001 as senior director of business development and has held positions of increasing responsibility.
"With the acquisition of Anchen and the pending acquisition of Edict, Par is becoming a larger and more complex organization with three diverse locations and more than 300 additional employees. These new challenges and opportunities require a president and a chief operating officer to effectively manage the company and its subsidiaries," LePore said in a statement. "Tom and Paul have been instrumental in Par’s many successes to date, and these expanded titles are a better reflection of their current responsibilities and achievements."
